SAB Biotherapeutics To Go Public Through Merger With Big Cypress Acquisition Corp.; Transaction Implies Enterprise Value Of $325M
SAB Biotherapeutics (SAB) has entered into a definitive merger agreement with Big Cypress Acquisition Corp. (NASDAQ:BCYP) and upon closing, the combined company is expected to be listed on NASDAQ
Anticipated resources